Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients? (WARD-OT)

Rigshospitalet logo

Rigshospitalet

Status

Enrolling

Conditions

Surgery-Complications
Chronic Obstructive Pulmonary Disease
Cancer

Treatments

Device: Active alarms from WARD software

Study type

Interventional

Funder types

Other

Identifiers

NCT06361862
WARD - Overtreatment

Details and patient eligibility

About

This aim of this study is to investigate whether active alerts during CVSM result in an increased number of diagnostic tests and treatments in complication free patients, hypothesizing that more interventions are performed in the CVSM-group than standard of care (EWS) group.

Enrollment

700 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

• Patients from WARD - RCT.

Exclusion criteria

-

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

700 participants in 2 patient groups

inactive alarms
No Intervention group
Description:
Patients with continuous monitoring without active alerts from WARD.
active alarms
Experimental group
Description:
Patients with continuous monitoring with active alerts from WARD.
Treatment:
Device: Active alarms from WARD software

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems